CRISPR and Gene Editing in Biologics Production
CRISPR-Cas9 gene editing technology has revolutionized various fields, including biologics production. By precisely modifying the genomes of cells used to produce therapeutic proteins, CRISPR offers several advantages:
- Enhanced Production: CRISPR can be used to optimize production host cells by increasing protein yield, improving product stability, and reducing the risk of contamination. For example, genes encoding enzymes involved in protein synthesis can be overexpressed, while genes responsible for unwanted byproducts can be inactivated.
- Improved Product Quality: CRISPR can be used to correct genetic defects in production cells that might lead to the production of misfolded or inactive proteins. This ensures the production of high-quality therapeutics with consistent potency and efficacy.
- Development of Novel Therapeutics: CRISPR can be used to engineer cells to produce novel therapeutic proteins with enhanced properties, such as increased stability, reduced immunogenicity, and improved targeting.
However, challenges remain, including off-target effects, potential for unintended mutations, and regulatory hurdles.
Visit our website to know more: https://www.leadventgrp.com/events/2nd-annual-bioprocessing-and-biologics-forum/details
For more information and group participation, contact us: [email protected]
Leadvent Group - Industry Leading Events for Business Leaders!
www.leadventgrp.com| [email protected]
